Correlation Between MetaLabs and Sk Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both MetaLabs and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MetaLabs and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MetaLabs Co and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on MetaLabs and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MetaLabs with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of MetaLabs and Sk Biopharmaceutica.

Diversification Opportunities for MetaLabs and Sk Biopharmaceutica

0.73

Correlation Coefficient

MetaLabs  Sk Biopharmaceutica

Poor diversification

The 3 months correlation between MetaLabs and 326030 is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding MetaLabs Co and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and MetaLabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MetaLabs Co are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of MetaLabs i.e., MetaLabs and Sk Biopharmaceutica go up and down completely randomly.

Pair Corralation between MetaLabs and Sk Biopharmaceutica

Assuming the 90 days trading horizon MetaLabs Co is expected to generate 0.82 times more return on investment than Sk Biopharmaceutica. However, MetaLabs Co is 1.22 times less risky than Sk Biopharmaceutica. It trades about 0.22 of its potential returns per unit of risk. Sk Biopharmaceuticals Co is currently generating about 0.09 per unit of risk. If you would invest  122,600  in MetaLabs Co on October 6, 2024 and sell it today you would earn a total of  13,400  from holding MetaLabs Co or generate 10.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

MetaLabs Co  vs.  Sk Biopharmaceuticals Co

MetaLabs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MetaLabs Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sk Biopharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sk Biopharmaceuticals Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Sk Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with MetaLabs and Sk Biopharmaceutica

The main advantage of trading using opposite MetaLabs and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MetaLabs position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.

The idea behind MetaLabs Co and Sk Biopharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.